In this study, we have found that the combination of Dox and CEA‐regulated OA CD55‐TMn exerted the synergic antitumour effect in HCC cells, compared to less than 10% inhibitory rate for Dox alone. Here, CD55 is linked to hepatocellular carcinoma.